Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: Nov 20, 2024, 4:00 PM
2.020
+0.010 (0.50%)
Pre-market: Nov 21, 2024, 7:10 AM EST
Company Description
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany.
It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Cronos Group Inc.
Country | Canada |
Founded | 2012 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 356 |
CEO | Michael Gorenstein |
Contact Details
Address: 111 Peter Street, Suite 300 Toronto, ON M5V 2H1 Canada | |
Phone | 416 504 0004 |
Website | thecronosgroup.com |
Stock Details
Ticker Symbol | CRON |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001603447 |
CUSIP Number | 22717L101 |
ISIN Number | CA22717L1013 |
Key Executives
Name | Position |
---|---|
Michael Ryan Gorenstein J.D. | President, Chief Executive Officer and Chairman |
James Holm | Chief Financial Officer |
Jeffrey David Jacobson | Chief Growth Officer |
Anna Shlimak | Chief Strategy Officer |
James Andrew McGinness III | Vice President, Controller and Principal Accounting Officer |
Shayne J. Laidlaw | Director of Investor Relations and Strategy |
Terry Gregory-Joseph Doucet | General Counsel and Corporate Secretary |
Shannon Buggy | Senior Vice President and Global Head of People |
Arye Weigensberg | Senior Vice President and Head of Research and Development |
Adam Wagner | Senior Vice President and Head of Cronos Israel |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 5, 2014 | D | Notice of Exempt Offering of Securities |
Apr 21, 2014 | D | Notice of Exempt Offering of Securities |
Mar 27, 2014 | D | Notice of Exempt Offering of Securities |